Obstetric anesthesia and postpartum mental health: implications from delivery to long-term recovery Authors: Sou-Hyun Lee, Kyung-Hwa Kwak Published: 2026 ABSTRACT AbstractObstetric anesthesiologists have traditionally focused on providing effective labor analgesia and ensuring safe cesarean delivery. However, growing evidence suggests that anesthetic choices and childbirth experiences influence maternal mental health beyond the immediate intrapartum period. Postpartum depression (PPD) and postpartum post-traumatic stress disorder (PP-PTSD) are linked to impaired maternal–infant bonding, reduced quality of life, and adverse long-term outcomes in mothers and children. Therefore, this review aimed to synthesize the current evidence on antenatal risk factors, delivery mode, anesthetic management, labor epidural analgesia (LEA), perioperative pharmacological prevention, and long-term outcomes, emphasizing the expanding role of obstetric anesthesiologists in postpartum mental health care. General anesthesia for cesarean delivery is linked to an increased risk of severe PPD and suicidality, although its relationship with PP-PTSD remains unclear. LEA does not appear to protect against PPD or PP-PTSD when assessed by binary exposure. Instead, the quality of pain relief, intraoperative pain, failed neuraxial anesthesia, and conversion to general anesthesia may be clinically relevant determinants of postpartum mental health. Perioperative ketamine and esketamine may help reduce the risk of early PPD following cesarean delivery, although evidence of sustained long-term benefits remains limited. These findings support an expanded role for obstetric anesthesiologists beyond intrapartum safety, including trauma-informed communication, optimized pain management, early identification of high-risk women, and prompt referral to multidisciplinary perinatal mental health care.Keywords: Analgesia, epidural; Anesthesia, obstetric; Cesarean section; Depression, postpartum; Ketamine; Stress disorders, post-traumatic INTRODUCTION Childbirth is one of the most significant physiological and psychological transitions in a woman’s life [1]. Among the postpartum mental health disorders, postpartum depression (PPD) and postpartum post-traumatic stress disorder (PP-PTSD) are particularly common. PPD affects approximately 12–17% of mothers [2-4], whereas PP-PTSD occurs in 3–10% of women after childbirth [5,6]. Both these disorders contribute substantially to maternal morbidity. PPD is associated with a poorer health-related quality of life, impaired maternal–infant bonding, and shorter breastfeeding durations [7,8]. Similarly, PP-PTSD is associated with a poorer postpartum quality of life, lower breastfeeding rates, and greater challenges in maternal–infant bonding [9-11]. Traditionally, obstetric anesthesia has primarily focused on providing effective labor analgesia, ensuring safe anesthetic management during cesarean delivery, and reducing anesthesia-related maternal morbidity and mortality [12-14]. However, growing evidence indicates that obstetric anesthesiologists may influence maternal mental health outcomes beyond the intrapartum period [15-18]. Accordingly, this review aimed to comprehensively summarize and analyze the current evidence on the effects of obstetric anesthesia on postpartum mental health, with particular emphasis on PPD and PP-PTSD from childbirth through long-term recovery. DEFINITION OF POSTPARTUM DEPRESSION AND ANTENATAL RISK FACTORS PPD is a major depressive disorder that develops within 1–12 months of childbirth [19]. In addition to the core symptoms of major depressive disorder, affected mothers may also experience obsessive concerns or preoccupations related to infant health, care, and safety [20]. Women with PPD often have multiple risk factors that precede pregnancy or arise during gestation. These factors can be categorized into several domains. Psychiatric history and psychological factors Psychiatric history and psychological factors are the major antenatal risk factors for PPD. During pregnancy, elevated anxiety is one of the strongest predictors of antenatal depression, while antenatal depression and a history of depression are associated with subsequent PPD, with reported odds ratios (ORs) of 2.40 and 3.09, respectively [3,21,22]. Approximately one-third of women with PPD experience depression before or during pregnancy [23], suggesting that PPD often develops in the context of preexisting perinatal psychiatric vulnerability. Psychosocial and demographic factors Psychosocial and demographic factors are also significant antenatal risk factors for PPD. The key risk factors include intimate partner violence, low educational attainment, limited social support, unmarried status, financial challenges, and unintended pregnancy [2,24]. Biological and medical factors Biological and medical factors may also increase vulnerability to PPD. Maternal smoking is associated with a more than four-fold increase in PPD risk, whereas obesity, defined as a body mass index (BMI) ≥ 35 kg/m2, is associated with an approximately three- to four-fold increased risk [25,26]. Sleep deprivation and gestational diabetes are significant risk factors for PPD [2,26]. DEFINITION OF POSTPARTUM POST-TRAUMATIC STRESS DISORDER AND ANTENATAL RISK FACTORS PP-PTSD, specifically childbirth-related PTSD, refers to PTSD symptoms that persist for more than 1 month after childbirth that is experienced as a traumatic event involving an actual or perceived threat of death or serious injury to the mother or infant [27]. Similar to PPD, PP-PTSD is often preceded by multiple antenatal vulnerabilities before labor or delivery. Psychiatric history and psychological factors Psychiatric history and mental health status are the strongest antenatal risk factors for PP-PTSD. Depression during pregnancy is the strongest antenatal predictor, followed by a history of pregnancy or birth-related psychological therapy [28]. Antenatal anxiety has been consistently associated with an increased risk of PP-PTSD in longitudinal cohort studies [29]. Additionally, preexisting PTSD is a significant vulnerability factor for PP-PTSD development [30]. These findings suggest that, similar to PPD, PP-PTSD often develops within the context of pre-existing perinatal psychiatric vulnerability. Psychosocial and demographic factors Low social support, poor coping capacity, and intimate partner violence during pregnancy are associated with PP-PTSD symptoms after childbirth [31,32]. Population-based data further suggest that socioeconomic deprivation, living without a partner, and limited access to healthcare professionals to discuss sensitive concerns during pregnancy are associated with PP-PTSD [33]. Biological and medical factors PP-PTSD is more strongly associated with pregnancy- and childbirth-related medical vulnerabilities than with lifestyle or metabolic factors. Unlike PPD, high BMI was not a significant risk factor for PP-PTSD [34]. A meta-analysis reported a moderate association between poor health and complications during pregnancy [28]. The prevalence of PP-PTSD is substantially higher in high-risk obstetric populations, reaching 16–19% among women with preterm birth, stillbirth, or preeclampsia, compared to approximately 4% in community samples [5,35]. Table 1 summarizes the antenatal risk factors for PPD and PP-PTSD. Table 1.Antenatal Risk Factors for PPD and PP-PTSDDomainPPDPP-PTSDPsychiatric and psychological factorsAntenatal anxiety, antenatal depression, history of depressionAntenatal anxiety, antenatal depression, previous pregnancy- or childbirth-related psychological therapy, preexisting PTSDPsychosocial and demographic factorsIntimate partner violence, low social support, low educational level, unmarried status/living without a partner, financial difficulties, unintended pregnancyIntimate partner violence, low social support, unmarried status/living without a partner, financial difficulties, and limited access to supportive healthcare professionalsBiological and medical factorsMaternal smoking, obesity (BMI ≥ 35 kg/m2), sleep deprivation, gestational diabetesPoor maternal health/pregnancy complications, high-risk obstetric conditions (preterm birth, stillbirth, preeclampsia)PPD: postpartum depression, PP-PTSD: postpartum post-traumatic stress disorder, BMI: body mass index. Antenatal Risk Factors for PPD and PP-PTSD PPD: postpartum depression, PP-PTSD: postpartum post-traumatic stress disorder, BMI: body mass index. DELIVERY METHOD: EFFECTS ON POSTPARTUM DEPRESSION AND POSTPARTUM POST-TRAUMATIC STRESS DISORDER Several large meta-analyses have examined the association between delivery mode and PPD, with most reporting only modest or heterogeneous associations. In a network meta-analysis, Sun et al. [36] report that cesarean section (CS) is associated with increased odds of PPD compared with vaginal delivery (VD) (OR, 1.33; 95% confidence interval [CI]: 1.21–1.46). However, CS is not significantly associated with severe PPD, defined by an Edinburgh Postnatal Depression Scale (EPDS) score ≥ 13 (OR, 1.07; 95% CI: 0.99–1.16). Another meta-analysis reports a pooled PPD prevalence of 13.4% among women undergoing CS and a modest increase in the adjusted odds of PPD compared to natural VD (adjusted OR, 1.12; 95% CI: 1.04–1.20) [37]. Subgroup analysis shows an increased PPD risk after emergency CS (adjusted OR, 1.20; 95% CI: 1.08–1.34), whereas elective CS is not associated with an increased risk (adjusted OR, 0.96; 95% CI: 0.83–1.10) [37]. Consistent with these findings, a nationwide Japanese cohort study showed that CS was only marginally associated with PPD at 1 month postpartum and not associated with PPD at 6 months postpartum after adjustment for antenatal physical health, socioeconomic status, and mental health variables [38]. Collectively, these findings suggest that CS should not be regarded as a uniform causal factor of PPD. The association between delivery mode and PP-PTSD appeared to be stronger, particularly in emergency or invasive deliveries. A meta-analysis reported that CS was more strongly associated with PP-PTSD than VD, with emergency CS showing a stronger association than elective CS. Instrumental VD was also associated with a higher risk of PP-PTSD than spontaneous VD, whereas emergency CS demonstrated the strongest association with PP-PTSD compared to spontaneous VD [39]. In a prospective cohort study, the overall prevalence of PP-PTSD 42 days postpartum was 12.12%, with higher rates after CS than after VD (17.55% vs. 8.18%) [40]. Compared to VD, both elective CS (relative risk [RR], 1.70; 95% CI: 1.03–2.87) and emergency CS (RR, 1.95; 95% CI: 1.08–3.83) are associated with increased PP-PTSD risk [40]. Data from a prospective French cohort further supported this gradient. PTSD symptoms at two months postpartum have been reported in approximately 4.9% of women after VD and 9.0% after CS [34,41]. Distinguishing between elective and emergency CS is also important. Emergency CS has demonstrated a more consistent association with depressive symptoms related to PPD than elective CS, for which the evidence remains inconclusive across meta-analyses [36,37]. One longitudinal cohort study showed that emergency CS was associated with PPD in unadjusted analyses (OR, 1.45; 95% CI: 1.04–2.01); however, this association was attenuated after adjusting for confounding factors, suggesting that postpartum complications and negative birth experiences may partially mediate this relationship [42]. Emergency CS is also consistently associated with a greater PP-PTSD symptom burden, potentially reflecting obstetric urgency and subjective experiences such as fear, loss of control, inadequate preparation, and reduced perceived support [39,40]. ANESTHESIA METHOD: EFFECTS ON POSTPARTUM DEPRESSION AND POSTPARTUM POST-TRAUMATIC STRESS DISORDER The effects of the anesthesia type are most relevant during CS, where neuraxial anesthesia is typically compared with general anesthesia. Two large retrospective cohort studies from New York State have provided consistent evidence supporting this association. In an initial cohort of 428,204 women undergoing CS, general anesthesia was associated with a 54% increase in the odds of PPD requiring hospitalization and a 91% increase in the odds of suicidal ideation or self-inflicted injury compared with neuraxial anesthesia [15]. However, general anesthesia was not significantly associated with PTSD [15]. A subsequent cohort study adjusted for obstetric complications reported similar findings. While general anesthesia is not significantly associated with overall PPD requiring any medical care (adjusted hazard ratio, 1.12; 95% CI: 0.97–1.30), it remains linked to a 38% increased risk of PPD requiring hospitalization and a 45% increased risk of suicidality [43]. Collectively, these findings suggest that general anesthesia may be associated with more severe depressive outcomes following CS. A nationwide, retrospective cohort study conducted in Taiwan reported similar findings [17]. However, residual confounding remains a major concern, as general anesthesia is commonly used for urgent, complicated, or high-risk cesarean deliveries [44]. The relationship between the type of anesthesia used during CS and PP-PTSD differed from that observed in PPD. In a prospective cohort study of women undergoing CS, maternal antepartum and intrapartum complications, anesthetic complications, and dissociative experiences during CS were significant predictors of PTSD profile [45], whereas general and neuraxial anesthesia were not [45]. Recently, a study involving mothers who were converted from inadequate neuraxial anesthesia to general anesthesia during CS reported that more than half of those who experienced intraoperative pain exhibited PTSD symptoms at 3 months postpartum [46]. These findings suggest that intraoperative pain may have a greater influence on PP-PTSD than the anesthesia type. LABOR EPIDURAL ANALGESIA (LEA) AND POSTPARTUM DEPRESSION/POSTPARTUM POST-TRAUMATIC STRESS DISORDER AFTER VAGINAL DELIVERY The relationship between LEA and postpartum mental health outcomes has been extensively examined for PPD but remains understudied for PP-PTSD. The current evidence suggests that LEA, when evaluated as a binary exposure, does not confer protection against either condition. Three meta-analyses consistently reported no significant association between LEA and PPD risk [47-49]. More recently, a cohort study suggested that the adequacy of pain relief, measured as the percentage reduction in pain, may be inversely associated with PPD symptoms, indicating that the analgesic quality, rather than LEA itself, may be a more relevant determinant [25]. However, subsequent commentaries urged caution due to methodological concerns, such as confounding by indication and limited statistical power, and emphasized that the multifactorial nature of PPD precludes significant modifications by a single anesthetic intervention [50,51]. Conceptually, effective labor analgesia may reduce the risk of PP-PTSD by alleviating severe pain and reducing perceived threat and loss of control during childbirth [28,52]. However, interpreting observational data remains challenging, as women requesting epidural analgesia often exhibit higher anxiety levels, greater pain sensitivity, or more negative childbirth expectations, all of which may confound the association between LEA and traumatic childbirth experiences [53,54]. Furthermore, the most recent meta-analysis of PP-PTSD did not generate a pooled estimate of the effect of epidural analgesia owing to substantial methodological heterogeneity across studies [49]. Collectively, the current evidence does not support LEA as an independent protective factor or risk factor for PPD or PP-PTSD after VD. Table 2 summarizes the current evidence on the effects of delivery mode, anesthesia method, and LEA on the risk of PPD and PP-PTSD. Table 2.Delivery- and Anesthesia-Related Factors in PPD and PP-PTSDFactorPPDPP-PTSDKey implicationCS vs. VDModest and heterogeneous association; no significant association with severe PPDHigher prevalence after CS than VDCS should not be considered a uniform causal factor for PPDEmergency vs. elective CSOnly emergency CS is consistently associated with PPD; elective CS shows no significant associationBoth increase risk, with emergency CS showing the strongest associationObstetric urgency and subjective childbirth experience (fear, loss of control) are central to PP-PTSDGeneral vs. neuraxial anesthesia for CSIncreased PPD risk requiring hospitalization and suicidality with general anesthesiaNo significant associationAnesthesia technique may influence severe PPD outcomes; however, residual confounding remains because general anesthesia is more commonly used in urgent/high-risk casesLEANo significant association across meta-analyses; analgesic quality may be more relevant than LEA use alonePooled estimate unavailable owing to substantial methodological heterogeneityLEA, as a binary exposure, is neither an independent protective factor nor a risk factorPPD: postpartum depression, PP-PTSD: postpartum post-traumatic stress disorder, CS: cesarean section, VD: vaginal delivery, LEA: labor epidural analgesia. Delivery- and Anesthesia-Related Factors in PPD and PP-PTSD PPD: postpartum depression, PP-PTSD: postpartum post-traumatic stress disorder, CS: cesarean section, VD: vaginal delivery, LEA: labor epidural analgesia. PHARMACOLOGICAL PREVENTION OF POSTPARTUM DEPRESSION: KETAMINE AND ESKETAMINE Ketamine and esketamine have attracted increasing attention as potential pharmacological interventions for PPD owing to their combined perioperative analgesic and antidepressant effects. Two recent meta-analyses consistently revealed that perioperative ketamine or esketamine significantly reduced both PPD risk and EPDS scores at 1 and 4–6 weeks postoperatively, with a moderate level of certainty [55,56]. Across these analyses, ketamine was administered as a single intravenous bolus of 0.25–0.5 mg/kg, whereas esketamine was administered at lower intravenous doses of 0.2–0.25 mg/kg. Both agents were administered either as a bolus at the time of delivery or as an adjuvant to patient-controlled intravenous analgesia (PCIA), with postoperative regimens increasing the cumulative dose to 2 mg/kg. Within these ranges, the total dose appeared to be a relatively weak determinant of efficacy, whereas postoperative administration, the PCIA route, and esketamine rather than ketamine were the regimen characteristics most consistently associated with sustained preventive effects at 4–6 weeks postpartum. Furthermore, a recent randomized trial extended this preventive approach by randomizing women with antenatal depression to intravenous administration of a single dose of esketamine (0.2 mg/kg) or placebo immediately after delivery [57]. The incidence of major depressive episodes throughout the 42 days postpartum was significantly lower in the esketamine group than in the placebo group [57]. Two additional randomized clinical trials further characterized perioperative esketamine regimens in women undergoing CS. In one trial, esketamine was administered as a single intravenous bolus (0.25 mg/kg after fetal delivery), followed by the addition of 50 mg to a 48-h PCIA regimen [58]. In another study, esketamine (0.25 mg/kg) diluted in 20 ml of saline was administered intravenously over 20 min after fetal delivery [59]. However, the preventive effect was not sustained beyond postpartum day 14 in a bolus-plus-PCIA study [58], and a separate study of epidural labor analgesia showed no significant preventive effect at 42 days postpartum [60]. The negative finding in the latter study should be interpreted in the context of epidural administration during spontaneous labor in a low-risk cohort, suggesting that the administration route and baseline symptom burden, rather than the dose alone, may influence the detectability of a preventive effect [60]. Consequently, although the total dose within the subanesthetic range appears to be a relatively weak determinant of efficacy, substantial heterogeneity in agent, dose, route, and timing across studies, together with the predominance of single-center trials, varying EPDS cut-off values, short follow-up duration, and publication bias, limits direct comparison among trials and precludes firm dosing recommendations. Overall, perioperative esketamine shows promise as an early preventive intervention. However, its long-term efficacy in PPD prevention remains unclear. Table 3 summarizes the dose, administration route, timing, and key findings of ketamine and esketamine studies evaluating PPD prevention. Table 3.Characteristics and Key Findings of Ketamine and Esketamine Studies for the Prevention of PPDStudyDrugDoseAdministration routeTimingKey findingLi et al., 2024 [55]Ketamine or esketamineVariableIV bolus or PCIAIntraoperative or postoperativeEsketamine, higher dose, and PCIA-based administration are associated with greater preventive efficacy.Hung et al., 2024 [56]Ketamine or esketamineIntraoperative: 0.2–0.5 mg/kg; postoperative: 0.1–2 mg/kgIV bolus, IV infusion, or PCIAIntraoperative or postoperativeThe preventive effect at 1 wk is observed regardless of timing, agent, or total dose, whereas the 4 to 6-wk benefit is more evident with postoperative administration or esketamine.Wang et al., 2024 [57]Esketamine0.2 mg/kgIV infusion over 40 minImmediately after deliveryA single low-dose IV infusion reduces the incidence of major depressive episodes through 42 d in mothers with antenatal depression.Chen et al., 2024 [58]Esketamine0.25 mg/kg IV + 50 mg/48 h PCIAIV bolus + PCIAIntraoperative (immediately after delivery), PCIA for 48 h after CSBolus-plus-PCIA administration improves early postpartum depressive symptoms, but the benefit does not persist beyond 14 d.Ren et al., 2025 [59]Esketamine0.25 mg/kg over 20 minIV infusion over 20 minIntraoperative (after delivery)A single intraoperative infusion reduces screen-positive PPD at 6 wk.Gao et al., 2026 [60]Esketamine0.5 mg/kg added to a 100 ml epidural analgesic solutionLEADuring laborEpidural esketamine combined with labor analgesia does not significantly reduce EPDS scores or screen-positive PPD at 42 d in a low-risk cohort.IV: intravenous, PCIA: patient-controlled intravenous analgesia, CS: cesarean section, LEA: labor epidural analgesia, PPD: postpartum depression, EPDS: Edinburgh Postnatal Depression Scale. Characteristics and Key Findings of Ketamine and Esketamine Studies for the Prevention of PPD IV: intravenous, PCIA: patient-controlled intravenous analgesia, CS: cesarean section, LEA: labor epidural analgesia, PPD: postpartum depression, EPDS: Edinburgh Postnatal Depression Scale. Long-term outcomes and recovery Postpartum mental health disorders often follow a chronic or recurrent course rather than resolving during early puerperium. Persistent PPD is linked to prolonged maternal depressive symptoms and adverse child outcomes that extend into adolescence [61]. Consistent with this pattern, another study reported substantial long-term psychiatric morbidity after PPD, including an increased risk of subsequent depressive episodes and recurrence after subsequent childbirths [62]. PP-PTSD may persist for a long time, with prospective studies documenting PTSD symptoms up to one year postpartum [63]. Negative early childbirth memories are also strongly correlated with the development of PTSD [64]. PP-PTSD symptoms are linked to impaired maternal–infant bonding throughout the first postpartum year and adverse behavioral outcomes [10,65]. Similarly, PPD is linked to impaired maternal–infant bonding, which may mediate subsequent psychosocial difficulties in children [66]. These persistent maternal and child effects indicate that postpartum mental health conditions cannot be adequately addressed by the early recognition of postpartum symptoms alone. Instead, systematic screening and early identification of high-risk women are required. SCREENING AND EARLY IDENTIFICATION Given the high prevalence and long-term consequences of PPD and PP-PTSD, systematic screening, early identification of high-risk women, and structured multidisciplinary collaboration are essential for perinatal mental health care. Role of the obstetric anesthesiologist in peripartum mental health screening Recent anesthesiology literature emphasizes that anesthesiologists are well positioned to prevent, recognize, and address PP-PTSD by promoting psychological safety during labor and delivery and identifying relevant symptoms and anesthetic risk factors [16]. Additionally, an obstetric anesthesia review highlighted that trauma-informed care may reduce PP-PTSD and maternal morbidity by optimizing analgesia, minimizing anesthetic complications, and identifying patients who perceive childbirth as traumatic [67]. The American Society of Anesthesiologists 2024 statement supports this expanded role by recommending the assessment of psychological stress, prompt correction of inadequate analgesia or anesthesia, and coordinated care of patients with preexisting mental health conditions or previous traumatic experiences [68]. From a PPD perspective, Du et al. [69] identified obstetric anesthesiologists as emerging key contributors to PPD prevention. This role encompasses the optimization of peripartum pain management and expansion of the use of perioperative ketamine and esketamine [69]. The EPDS is a 10-item instrument that requires approximately 5 min to complete and is the most widely used international screening tool for PPD [70]. For PP-PTSD, validated screening tools include the Primary Care PTSD Screen for Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) [71] and the City Birth Trauma Scale [72]. High-risk identification and referral pathways The identification of high-risk women should target those with established antenatal risk factors for PPD and PP-PTSD. These include a personal or family history of depression or anxiety, prior PTSD or psychiatric treatment, intimate partner violence or other interpersonal trauma, antenatal depressive or anxiety symptoms, prior traumatic childbirth, fear of childbirth, and adverse obstetric or social conditions [16,67,73]. Although infertility can represent a significant reproductive and psychosocial stressor, recent studies have not consistently reported it as an independent risk factor for PPD [74,75]. Evidence linking infertility to PP-PTSD remains limited, and prospective cohort studies have shown no significant association between mode of conception and PP-PTSD development [76]. In obstetric anesthesia practice, additional intrapartum and postoperative indicators of elevated PP-PTSD risk include severe intraoperative pain, conversion from neuraxial to general anesthesia, anesthesia-related complications, and emergency CS [16,45]. Practical implementation may include shared screening workflows using validated tools for depression and birth-related trauma alongside structured referral pathways that enable obstetric anesthesiologists to identify high-risk patients for prompt mental health evaluation. Future studies should explore the implementation of postpartum anesthetic follow-up in women with inadequate analgesia, intraoperative pain, neuraxial block failure, conversion to general anesthesia, or other anesthetic complications [16,67,68,77]. KOREAN EVIDENCE IN THE CONTEXT OF INTERNATIONAL FINDINGS Because the social and psychiatric context of childbirth in Korea may differ from that of the predominantly non-Korean population discussed earlier, the applicability of these findings to Korean mothers warrants specific consideration. Regarding disease prevalence, Korean screening-based estimates are generally comparable to or higher than the 12–17% global prevalence of PPD previously described in this review. The Korean Pregnancy Outcome Study reported a PPD prevalence of 16.3% and identified factors associated with PPD, including depressive symptoms during early pregnancy, postpartum stress, fear, sadness, impaired mother–child relationships, reduced quality of life, low marital satisfaction, and neonatal intensive care unit admission [78]. Similarly, a large home visitation cohort in Seoul reported that 24.3% of postpartum women tested positive for PPD [79]. This study showed that low income, single parenthood, recent stress or loss, prior treatment for emotional problems, childhood abuse, and domestic violence were associated with an increased risk of peripartum depression. In contrast, support for infant care and emotional support served as protective factors [79]. A nationally representative Korean study reported that low or moderate social support was associated with higher odds of PPD, particularly among women with multiparity, pregnancy loss, negative body image, or employment [80]. Conversely, a nationwide claims-based study reported a clinically diagnosed PPD prevalence of 1.4% among Korean women and identified CS and labor induction as obstetric risk factors [81]. The discrepancy between symptom-based screening and claims-based diagnosis indicates that measurement methods, healthcare-seeking behaviors, under-recognition, and stigma may substantially influence disease burden estimates in Korea. Overall, the Korean data align well with international findings, highlighting antenatal psychiatric vulnerability, social adversity, limited social support, and adverse obstetric experiences as key risk factors. Research on PP-PTSD in Korea is limited compared to the international literature. A previous study on Korean women who experienced traumatic childbirth highlighted key themes, including pain, guilt, conflicts with maternal identity, damaged femininity, threatened dignity, and disrupted relationships [82]. These findings suggest that culturally specific expectations regarding motherhood, body image, spousal support, and a respectful childbirth environment may influence traumatic childbirth experiences in Korea. Although perioperative ketamine and esketamine are promising agents for early PPD prevention, randomized trials have been conducted primarily in non-Korean populations. Currently, no comparable anesthesia-focused trials have been conducted in the domestic obstetric population. These findings suggest that international evidence on obstetric anesthesia should be applied with caution in Korean parturients. Therefore, population-specific research is required on peripartum screening, delivery- and analgesia-related risk factors, and perioperative pharmacological prevention. CONCLUSION This review supports the redefinition of the role of obstetric anesthesiologists in postpartum mental health care. PPD and PP-PTSD are multifactorial conditions influenced by antenatal vulnerability, delivery context, anesthetic technique, pain experience, anesthetic complications, and early postpartum recovery. General anesthesia for CS is linked to more severe depressive outcomes, whereas LEA shows inconsistent effects on PPD risk and limited evidence regarding PP-PTSD. Factors including the quality of intrapartum pain relief, intraoperative pain, neuraxial block failure, conversion to general anesthesia, perceived loss of control, and negative childbirth memories appear to be more clinically relevant than anesthetic techniques alone. Perioperative ketamine and esketamine show promise for early PPD prevention, particularly after CS or among women with antenatal depressive symptoms, although their long-term efficacy and effects on PP-PTSD remain unclear. Key knowledge gaps include standardized analgesic adequacy measures, anesthesia-based screening and referral pathways, and the long-term effects of anesthesia and childbirth experiences on maternal recovery, maternal–infant bonding, and child outcomes. Through trauma-informed communication, optimized pain management, early identification of high-risk women, structured referral pathways, and postpartum anesthetic follow-up, obstetric anesthesia can be expanded beyond intrapartum safety to support maternal mental health throughout the perinatal period. Footnotes FUNDING None. CONFLICTS OF INTEREST No potential conflict of interest relevant to this article was reported. DATA AVAILABILITY STATEMENT Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study. AUTHOR CONTRIBUTIONS Conceptualization: Kyung-Hwa Kwak. Writing - original draft: Sou-Hyun Lee, Kyung-Hwa Kwak. Writing - review & editing: Sou-Hyun Lee, Kyung-Hwa Kwak. REFERENCES